Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up june 1st, 2025
Awards & highlights
Summary
Early identification of intracranial atherosclerotic disease (ICAD) may impact the management of patients undergoing mechanical thrombectomy (MT). The aim of the study is to develop and validate a scoring system for pre-thrombectomy diagnosis of ICAD in posterior circulation large vessel/distal medium vessel occlusion strokes (LVOs/DMVOs).
Eligible Conditions
- Ischemic Stroke
- Stroke
- Intracranial Artery Stenosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ june 1st, 2025
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~june 1st, 2025
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Post-procedural outcomes included any intracranial hemorrhage, symptomatic ICH (sICH)
Secondary study objectives
90 day modified Rankin scale (mRS)
Trial Design
2Treatment groups
Experimental Treatment
Group I: Non-ICAD cases (controls)Experimental Treatment1 Intervention
Non-ICAD cases (controls) includes patients with posterior circulation stroke attributed to stroke etiologies other than ICAD.
Group II: ICAD groupExperimental Treatment1 Intervention
includes ICAD-related stroke made when a smooth-bordered lesions leading to delayed perfusion on conventional-angiography (without competing stroke etiology) or when irregular-surfaced lesions involving the target vessel during mechanical thrombectomy were unveiled (with or without competing stroke etiology).
Find a Location
Who is running the clinical trial?
Sohag UniversityLead Sponsor
761 Previous Clinical Trials
91,632 Total Patients Enrolled
1 Trials studying Stroke
100 Patients Enrolled for Stroke
Emory UniversityOTHER
1,679 Previous Clinical Trials
2,583,516 Total Patients Enrolled
31 Trials studying Stroke
350,032 Patients Enrolled for Stroke
Share this study with friends
Copy Link
Messenger